Glaxosmithkline Pharmaceuticals Ltd.
Share Price Target & Analysis
NSE:GLAXO
VWAP
Open
Close
High
Low
52 Week High
-4.90 (-0.25%)
GLAXO
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: GLAXO Share Price Financial Analysis & Valuation
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Mid Cap company with Market Capitalization of Rs 27996 (in Cr). Total number of free float shares are 16.9 (in Lacs).
Glaxosmithkline Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE159A01016 and trading code is NSE:GLAXO with short name GlaxoSmithKline.
In the past 1 year, Glaxosmithkline Pharmaceuticals Ltd. has declared an equity dividend of Rs 32 per share. At the current share price of GLAXO at Rs 1994.45, this results in a dividend yield of 1.6 %.
As per the Fundamental Analysis of NSE:GLAXO, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLAXO underlying value and future prospects. All of this data is available in GLAXO financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:GLAXO, it is clearly understood that GLAXO is Economical performer in terms of earnings and profit margins with an EPS of 30.88. NSE:GLAXO book value per share as of today is 103.58. The current price to book ratio for GLAXO as of May 15, 2024 is 19.26.
Valuation of the Stock: The current valuation of GLAXO stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLAXO whether to BUY this stock at current valuation. The delivery percentage of GLAXO is 53.87% is very crucial parameter which shows that 53.87% investors are anticipating that the price of GLAXO share should go up with VWAP at 1997.99.
Now, the main question is whether to BUY or SELL, NSE:GLAXO at current valuation.
As per latest Analysis No. #569:-
⇑ STRONG BUY GLAXO if All Greens
⇗ BUY GLAXO (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD GLAXO (With Stop Loss) if only 1 Green
⇘ SELL GLAXO if NO Green Indicator
NSE: GLAXO Share Price Today (May 15, 2024)
(Glaxosmithkline Pharmaceuticals Ltd. Daily Analysis on the basis of GLAXO Intraday Graph & Trend)
Glaxosmithkline Pharmaceuticals Ltd. share price moved Down by -0.25% from its previous close of Rs 1999.35. GLAXO stock last traded price is 1994.45. GLAXO share price trend is Down with a total of 36943 stocks traded till now. It has touched an intraday high of Rs 2020.00 and an intraday low of Rs 1984.00. The GLAXO trading at 1994.45, Down by Rs. -4.90, or -0.25 percent which suggests that most of the Traders are anticipating that the price of GLAXO share should go Down.
NSE: GLAXO Share Price Tomorrow Prediction
(Glaxosmithkline Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLAXO)
Glaxosmithkline Pharmaceuticals Ltd. share price moved Down by -0.25%. GLAXO share price short term trend is Down. It suggests that GLAXO Share Price for Tomorrow remains the same with VWAP at 1997.99 will be treated as stop loss for intraday traders. Glaxosmithkline Pharmaceuticals Ltd. Long term investors can follow the GLAXO long term trend as mentiond in future forecast table.
NSE Code |
NSE: GLAXO |
GLAXO Share Price Today |
1994.45 |
GLAXO Share Price Target Prediction for 2024 ^ |
1804.8 - 2536.5 |
GLAXO Share Price Target Prediction for 2025*^ |
2536.5 - 2702.2 |
GLAXO Share Price Target Prediction for 2026*^ |
2702.2 - 2891.4 |
GLAXO Share Price Target Prediction for 2027*^ |
3036 |
GLAXO Share Price Target Prediction for 2028*^ |
3123 |
GLAXO Share Price Target Prediction for 2030*^ |
3404 |
GLAXO Current Book Value 2023 |
103.1 |
*Glaxosmithkline Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLAXO share price target prediction for 2024 2025 & 2026 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
GLAXO Technical Analysis
Candlestick Pattern: @2112.85MA | Simple | Action S1 | Expo | Action E2 |
---|---|---|---|---|
MA_5 | 2066.22 | BUY | 2068.12 | BUY |
MA_12 | 1963.76 | BUY | 2004 | BUY |
MA_20 | 1960 | BUY | 1991.52 | BUY |
MA_32 | 1965.57 | BUY | 2000.98 | BUY |
MA_50 | 2036.47 | BUY | 2010.9 | BUY |
MA_100 | 2082.65 | BUY | 1981.94 | BUY |
MA_200 | 1760.44 | BUY | 1825.21 | BUY |
Trend Oscillators | Value | Action |
---|---|---|
Bollinger Bands | 2110.29 | OverBought |
MACD | 32.26 | BUY |
ADX | 28.28 | Strong Trend |
DMI (+/-) | 30.19 / 13.2 | Uptrend |
Momentum Oscillators | Value | Action |
---|---|---|
RSI | 64.06 | Neutral |
STOCHASTIC_K (Fast) | 82.76 | Overbought |
STOCHASTIC_D (Slow) | 87.33 | Overbought |
CCI | 151.63 | BUY |
PSAR | 1875.2 | BUY |
TRUE RANGE | 66.4 | BUY |
ATR | 69.13 | BUY |
WILLIAMS R | -16.25 | Overbought |
TRIX | 0 | Neutral |
STOCHASTIC RSI K | 87.27 | Overbought |
STOCHASTIC RSI D | 93.75 | Overbought |
MOMENTUM | 191.35 | BUY |
Duration | Value |
---|---|
1 Year | 69.67% |
3 Months | -6.91% |
1 Month | 9.96% |
1 Week | 8.35% |
Action | Overall (%) |
---|---|
BUY | 93% |
NEUTRAL / HOLD | 7% |
SELL | 0% |
Most popular Questions & Answers about GLAXO
Glaxosmithkline Pharmaceuticals Ltd. stock last traded price is 1994.45. GLAXO share price moved Down by -0.25% from its previous close of Rs 1999.35.
Glaxosmithkline Pharmaceuticals Ltd. share price trend is Down with a total of 36943 stocks traded till now. It has touched an intraday high of Rs 2549.24 and an intraday low of Rs 1984.00. The GLAXO trading at 1994.45, Down by Rs. -4.90, or -0.25 percent which suggests that most of the Traders are anticipating that the price of GLAXO share should go Down and the Stop Loss will be around 1997.99.
The market cap of Glaxosmithkline Pharmaceuticals Ltd. is ₹27996 (in Cr) as of May 14, 2024.
The current price to earning ratio for Glaxosmithkline Pharmaceuticals Ltd. as of May 14, 2024 is 46.42.
The current price to book ratio for Glaxosmithkline Pharmaceuticals Ltd. as of May 14, 2024 is 19.26.
The highest price of Glaxosmithkline Pharmaceuticals Ltd. stock is ₹2524.00 in the last 52-week.
The lowest price of Glaxosmithkline Pharmaceuticals Ltd. stock is ₹1227.00 in the last 52-week.
Glaxosmithkline Pharmaceuticals Ltd. share trading at ₹1994.45, Down by Rs. -4.90, or -0.25 percent which suggests that most of the traders are anticipating that the price of GLAXO share should go Down.
In 2023, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) are ₹1804.8 on downside and ₹2536.5 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.
In 2024, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) are ₹2536.5 on downside and ₹2702.2 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.
In 2025, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) are ₹2702.2 on downside and ₹2891.4 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) will be around ₹3123 Glaxosmithkline Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLAXO.
As per the fundamental analysis of Glaxosmithkline Pharmaceuticals Ltd. (GLAXO), it is of Economical quality in terms of earnings and profit margins with an EPS of 30.88. Glaxosmithkline Pharmaceuticals Ltd. book value per share as of today is 103.58. The current price to book ratio for GLAXO as of May 15, 2024 is 19.26.
NSE:GLAXO News & Other Useful Information about GLAXO Share Price
Peer Comparison of NSE: GLAXO
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
Company | Price | EPS | BV |
---|---|---|---|
SUNPHARMA | 1545.25 | 4.04 | 98.98 |
DIVISLAB | 3896.20 | 51.37 | 478.6 |
MEDICAMEQ | 496.40 | 11.2 | 151.58 |
CIPLA | 1358.20 | 50.5 | 305.16 |
DRREDDY | 5873.00 | 260.29 | 1227.38 |
PGHH | 4751.70 | 189.8 | 447.64 |
TORNTPHARM | 2630.00 | 34.45 | 187.49 |
BIOCON | 310.90 | 15.96 | 90.91 |
LUPIN | 1637.15 | 51.04 | 403.99 |
ALKEM | 5183.20 | 140.26 | 781.99 |